Medical marketers are ready to move away from AI as a buzzword while sports marketing opportunities emerge at Digital Pharma ...

The Roche Digital Pathology Open Environment brings together a wide array of innovative AI-based pathology tools to help clinicians improve patient care and expand personalised healthcare.Roche ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced detailed final overall survival (OS) results from CONTACT-02, a phase 3 pivotal study evaluating cabozantinib (CABOMETYX ...

Though the new shuttles will be emblazoned with the city logo, they will be operated by Via, a transportation company that currently ... such as Google and Genentech. Some will be hybrids, others ...

Regulatory News: BenevolentAI ("BenevolentAI" or "the Company" or "the Group") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces its ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...

The recent decision to merge Genentech’s two cancer departments was made for “scientific reasons,” executives explained to ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Genentech has received Food and Drug Administration approval for its treatment of certain types of lung, liver, skin and soft tissue cancer in adults.

The FDA approval is based on data from Genentech's Phase IB/III IMscin001 study, according to the company, which showed comparable levels of Tecentriq in the blood, "when administered ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...